A smart beta exchange traded fund, the iShares Biotechnology ETF (IBB) debuted on 02/05/2001, and offers broad exposure to ...
JAAA: $46.41 million (5.7% of AUM) VUG: $40.11 million (4.9% of AUM) DFLV: $32.03 million (3.9% of AUM) JCPB: $28.13 million (3.45% of AUM) AMZN: $27.70 million (3.4% of AUM) As of Tuesday afternoon, ...
If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund ...
Today, Zacks Investment Ideas feature highlights iShares Biotechnology ETF IBB, Novartis NVS, Pfizer PFE and Eli Lilly’s LLY. Biotech's Silent ...
Investors in iShares Trust - iShares Biotechnology ETF (Symbol: IBB) saw new options begin trading today, for the December 19th expiration. One of the key data points that goes into the price an ...
The iShares Biotechnology ETF (IBB) was launched on 02/05/2001, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market. What Are Smart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results